Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Cucurbitacin B and its rapidly emerging role in the management of systemic malignancies besides lung carcinomas.

Kapoor S.

Cancer Biother Radiopharm. 2013 May;28(4):359. doi: 10.1089/cbr.2012.1373. Epub 2013 Jan 25. No abstract available.

PMID:
23350897
2.

Cucurbitacin B induces apoptosis and S phase cell cycle arrest in BEL-7402 human hepatocellular carcinoma cells and is effective via oral administration.

Chan KT, Meng FY, Li Q, Ho CY, Lam TS, To Y, Lee WH, Li M, Chu KH, Toh M.

Cancer Lett. 2010 Aug 1;294(1):118-24. doi: 10.1016/j.canlet.2010.01.029. Epub 2010 Feb 11.

PMID:
20153103
3.

[Effects of Sema3A derived from tumor cells on functions of dendritic cells].

Zhou XL, Huang Y, Wang F, Cai LF, Zhang LH, Shi LY.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2010 Jul;39(4):364-9. Chinese.

PMID:
20731034
4.

An in situ autologous tumor vaccination with combined radiation therapy and TLR9 agonist therapy.

Zhang H, Liu L, Yu D, Kandimalla ER, Sun HB, Agrawal S, Guha C.

PLoS One. 2012;7(5):e38111. doi: 10.1371/journal.pone.0038111. Epub 2012 May 30.

5.

Plasmacytoid dendritic cells play a key role in tumor progression in lipopolysaccharide-stimulated lung tumor-bearing mice.

Rega A, Terlizzi M, Luciano A, Forte G, Crother TR, Arra C, Arditi M, Pinto A, Sorrentino R.

J Immunol. 2013 Mar 1;190(5):2391-402. doi: 10.4049/jimmunol.1202086. Epub 2013 Jan 25.

6.

Inhibitory effect of cucurbitacin E on pancreatic cancer cells growth via STAT3 signaling.

Sun C, Zhang M, Shan X, Zhou X, Yang J, Wang Y, Li-Ling J, Deng Y.

J Cancer Res Clin Oncol. 2010 Apr;136(4):603-10. doi: 10.1007/s00432-009-0698-x. Epub 2009 Oct 9.

PMID:
19816711
7.

Inhibition of delayed-type hypersensitivity by Cucurbitacin R through the curbing of lymphocyte proliferation and cytokine expression by means of nuclear factor AT translocation to the nucleus.

Escandell JM, Recio MC, Giner RM, Máñez S, Cerdá-Nicolás M, Merfort I, Ríos JL.

J Pharmacol Exp Ther. 2010 Feb;332(2):352-63. doi: 10.1124/jpet.109.159327. Epub 2009 Oct 21.

8.

Cucurbitacin E inhibits breast tumor metastasis by suppressing cell migration and invasion.

Zhang T, Li J, Dong Y, Zhai D, Lai L, Dai F, Deng H, Chen Y, Liu M, Yi Z.

Breast Cancer Res Treat. 2012 Sep;135(2):445-58. doi: 10.1007/s10549-012-2175-5. Epub 2012 Jul 28.

PMID:
22842972
9.

Immunomodulatory activity of cucurbitacin E isolated from Ecballium elaterium.

Attard E, Brincat MP, Cuschieri A.

Fitoterapia. 2005 Jul;76(5):439-41.

PMID:
15908139
10.

Nicotine stimulated dendritic cells could achieve anti-tumor effects in mouse lung and liver cancer.

Gao FG, Li HT, Li ZJ, Gu JR.

J Clin Immunol. 2011 Feb;31(1):80-8. doi: 10.1007/s10875-010-9459-5. Epub 2010 Oct 19.

PMID:
20957418
11.

Plasmacytoid dendritic cells contribute to doxorubicin-induced tumor arrest in a mouse model of pulmonary metastasis.

Terlizzi M, Popolo A, Pinto A, Sorrentino R.

J Immunother. 2014 May;37(4):214-24. doi: 10.1097/CJI.0000000000000026.

PMID:
24714355
12.

The antimetastatic and immunomodulating activities of ginseng minor glycosides.

Popov AM, Atopkina LN, Uvarova NI, Elyakov GB.

Dokl Biochem Biophys. 2001 Sep-Oct;380:309-12. No abstract available.

PMID:
11727551
13.

The induction of G2/M cell-cycle arrest and apoptosis by cucurbitacin E is associated with increased phosphorylation of eIF2alpha in leukemia cells.

Li Y, Wang R, Ma E, Deng Y, Wang X, Xiao J, Jing Y.

Anticancer Drugs. 2010 Apr;21(4):389-400. doi: 10.1097/CAD.0b013e328336b383.

PMID:
20110807
14.

Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer.

Antonia SJ, Mirza N, Fricke I, Chiappori A, Thompson P, Williams N, Bepler G, Simon G, Janssen W, Lee JH, Menander K, Chada S, Gabrilovich DI.

Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):878-87.

15.

Dammarane-type saponins from heat-processed Gynostemma pentaphyllum show fortified activity against A549 cells.

Piao XL, Wu Q, Yang J, Park SY, Chen DJ, Liu HM.

Arch Pharm Res. 2013 Jul;36(7):874-9. doi: 10.1007/s12272-013-0086-6. Epub 2013 Mar 19.

PMID:
23508742
17.

Direct effects of carbon nanotubes on dendritic cells induce immune suppression upon pulmonary exposure.

Tkach AV, Shurin GV, Shurin MR, Kisin ER, Murray AR, Young SH, Star A, Fadeel B, Kagan VE, Shvedova AA.

ACS Nano. 2011 Jul 26;5(7):5755-62. doi: 10.1021/nn2014479. Epub 2011 Jun 15.

18.

Cancer immunotherapeutic potential of novel small molecule TLR7 and TLR8 agonists.

Hamm S, Rath S, Michel S, Baumgartner R.

J Immunotoxicol. 2009 Dec;6(4):257-65. doi: 10.3109/15476910903286733.

PMID:
19848448
19.

Feasibility study of adoptive immunotherapy for metastatic lung tumors using peptide-pulsed dendritic cell-activated killer (PDAK) cells.

Yamaguchi Y, Ohta K, Kawabuchi Y, Ohshita A, Okita R, Okawaki M, Hironaka K, Matsuura K, Toge T.

Anticancer Res. 2005 May-Jun;25(3c):2407-15.

20.

Combined stimulation with interleukin-18 and CpG induces murine natural killer dendritic cells to produce IFN-gamma and inhibit tumor growth.

Chaudhry UI, Kingham TP, Plitas G, Katz SC, Raab JR, DeMatteo RP.

Cancer Res. 2006 Nov 1;66(21):10497-504.

Supplemental Content

Support Center